Pursuant to Regulation 29 and 50 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dishman Carbogen Amcis has informed that the meeting of the Board of Directors of the Company will be held on Tuesday, the 23rd day of May, 2023, to consider, take on record and approve the Audited Financial Results of the Company for the quarter and year ended on 31st March, 2023. Also, the Trading Window for dealing in the securities of the Company will open from 26th May, 2023. The Trading Window would remain closed from 1st April, 2023 to 25th May, 2023 for dealing in Securities of the Company by all the Directors, Designated Persons and their immediate relative(s).
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: